New drugs for breast cancer, lymphoma, multiple sclerosis and migraine are among new product launches this year that could top $1 billion in annual sales by 2024, according to Clarivate.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,